Abstract
The synthesis and structure-activity relationship (SAR) of a series of pyridyl-isoxazole based agonists of S1P1 are discussed. Compound 5b provided potent in vitro activity with selectivity, had an acceptable pharmacokinetic profile, and demonstrated efficacy in a dose dependent manner when administered orally in a rodent model of arthritis.
Keywords:
FTY720; Fingolimod; Isoxazole; S1P(1); Sphingosine-1-phosphate; Sphingosine-1-phosphate 1.
Copyright © 2016 Elsevier Ltd. All rights reserved.
MeSH terms
-
Administration, Oral
-
Animals
-
Arthritis, Experimental / drug therapy*
-
Chemistry Techniques, Synthetic
-
Dose-Response Relationship, Drug
-
Drug Evaluation, Preclinical / methods
-
Humans
-
Isoxazoles / chemistry
-
Isoxazoles / pharmacology
-
Lymphocyte Count
-
Lysophospholipids / agonists*
-
Male
-
Rats, Inbred Lew
-
Receptors, Lysosphingolipid / agonists
-
Sphingosine / agonists
-
Sphingosine / analogs & derivatives*
-
Structure-Activity Relationship*
Substances
-
Isoxazoles
-
Lysophospholipids
-
Receptors, Lysosphingolipid
-
sphingosine 1-phosphate
-
Sphingosine